Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
1.830
-0.120 (-6.15%)
At close: Oct 10, 2025, 4:00 PM EDT
1.820
-0.010 (-0.55%)
After-hours: Oct 10, 2025, 7:58 PM EDT
Cognition Therapeutics Market Cap
Cognition Therapeutics has a market cap or net worth of $161.45 million as of October 10, 2025. Its market cap has increased by 869.37% in one year.
Market Cap
161.45M
Enterprise Value
151.17M
1-Year Change
869.37%
Ranking
Category
Stock Price
$1.83
Market Cap Chart
Since the IPO on October 8, 2021, Cognition Therapeutics's market cap has decreased from $256.46M to $161.45M, a decrease of -37.05%. That is a compound annual growth rate of -10.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 161.45M | 454.09% |
| Dec 31, 2024 | 29.14M | -50.97% |
| Dec 29, 2023 | 59.43M | -2.39% |
| Dec 30, 2022 | 60.88M | -56.29% |
| Dec 31, 2021 | 139.27M | -45.69% |
| Oct 8, 2021 | 256.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 759.23B |
| Johnson & Johnson | 456.84B |
| AbbVie | 408.50B |
| UnitedHealth Group | 335.03B |
| AstraZeneca | 266.28B |
| Novo Nordisk | 265.74B |
| Novartis AG | 257.26B |
| Abbott Laboratories | 233.69B |